Bovine Lymphoma (Leukosis, BLV) Study Guide
Overview and Clinical Importance
Bovine leukemia virus (BLV) is an oncogenic deltaretrovirus closely related to human T-lymphotropic virus types 1 and 2. BLV is the causative agent of enzootic bovine leukosis (EBL), the most common neoplastic disease in cattle worldwide. The virus integrates into B-lymphocyte DNA, creating a lifelong infection.
BLV infection follows a predictable progression: approximately 70% of infected cattle remain asymptomatic, about 30% develop persistent lymphocytosis (PL), and fewer than 5% develop lymphosarcoma (also called lymphoma), typically in cattle aged 4-8 years. The economic impact is substantial, with losses from reduced milk production, premature culling, carcass condemnation, and trade restrictions.
Etiology and Classification
Bovine Leukemia Virus Characteristics
BLV is an exogenous C-type oncogenic retrovirus belonging to the genus Deltaretrovirus, family Retroviridae. Key viral characteristics include: stable genome with approximately 97% nucleotide sequence homology among strains worldwide; integration into host B-lymphocyte DNA as a provirus; primary target cells are CD5+ IgM+ B-lymphocytes; the virus does not cause chronic viremia; and infection results in persistent antibody production.
You've been studying hard
Create a free account to keep reading
Free accounts get 5 articles/day + daily practice questionJoin vet students already studying with NavleExam.
No credit card needed — free account takes 30 seconds.
Create Free Account — Keep Reading Already have an account? Log inNo spam. One question per day. Unsubscribe anytime.
Take the free NAVLE practice exam
50 exam-style questions across the NAVLE species. See your score as soon as you finish, then get the full answer key with explanations by email. No payment, no account.
Start the free exam →